WuXi AppTec Life Science and Chemistry Award 2008 Launched Warmly
Sep 23, 2008
September 23, 2008 - Shanghai, China -Based on its first success in 2007, the selection of WuXi AppTec Life Science and Chemistry Award 2008 has been launched warmly.
The WuXi AppTec Life Science and Chemistry Award was approved and endorsed by the National Office of Science and Technology Awards in early 2007, designed to promote China's scientific and technological development in chemistry, life science, medicinal, and pharmaceutical industries. WuXi AppTec, the first and the only scientific research company that sets up the research award of life science and chemistry fields in China, will reward young professionals of Chinese citizenship who make an outstanding achievement in the field of chemistry, biology, or other life science related disciplines.
WuXi AppTec provides one million RMB to fund this annual project rewarding at most 20 outstanding scientific and technological talents every year. The special prize winners, first prize winners, second prize winners and third prize winners will get a reward of 200,000 RMB, 100,000 RMB, 50,000 RMB and 20,000 RMB respectively.
For the first WuXi AppTec Life Science and Chemistry Award 2007, Mr. Xu
Guanhua, the former Minister of the Ministry of Science and Technology
served as Chairman of the management panel and Mr. Cheng Jinpei, the Vice
Minister of the Ministry of Science and Technology, as Chairman of the
selection panel. Besides, Mr. Zhang Huaixi and Mr. Li Meng, both Vice Chairmen
of the National Committee of the Chinese People's Political Consultative
Conference (CPPCC), and Mr. Gao Huchen, the Vice Minister of the Ministry
of Commerce attended the ceremony and presented the awards to 17 young
professionals in honor of their outstanding achievements in life science
and chemistry fields.
For this year, Mr. Sang Guowei, member of the Standing Committee of the National People's Congress, deputy director of Committee of Education, Science, Culture and Health, and board chairperson of Chinese Pharmaceutical Association, serves as Chairman of both management and selection panels. The scope of the award selection for this year is settled on toxicology, in which circle the predominant scientific research achievements are currently collected which raises strong repercussions throughout related colleges, universities and scientific research institutions in China. The selection panel has been established and the prize winning academic results will be unveiled at the Great Hall of People in Beijing on Dec. 7 2008.
strong social responsibility WuXi AppTec founded this research
award, aiming to cultivate and encourage young scientists to reach the
summit of science and technology as well as facilitating their career development
on the one hand, and on the other hand to play our predominant impact in
drug discovery with achieving the great combination of industry, academy
and research, which reflects WuXi AppTec's duty-bound role of contributing
to the fast evolvement of Chinese pharmaceutical industry.
As a leading global pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the U.S, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to pharmaceutical, biotechnology and medical device companies. Currently we have become the largest pharmaceutical research company around the world covering chemical and small molecule services. Except our facilities in Shanghai Waigaoqiao Free Trade Zone, Shanghai Jinshan Area, Tianjin and Suzhou, our U.S.-based facilities include St. Paul, Minnesota, Atlanta, Georgia and Philadelphia, Pennsylvania. Our customers include 9 of the top 10 pharmaceutical companies in the world and most of tem come back to us for larger and longer-term cooperation. Presently an over-30,000-sq.-mt. facility is under construction in our Suzhou location to provide world-class preclinical contract research services. The state-of-the-art facility is totally designed to meet the United States Food and Drug Administration and worldwide regulatory standards and will be completed being the largest non-clinical study of drug evaluation center in Asia by 2009.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.